RSCM

Rock Springs Capital Management Portfolio holdings

AUM $1.6B
1-Year Return 25.98%
This Quarter Return
+17.22%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$2.6B
AUM Growth
+$258M
Cap. Flow
+$1.53M
Cap. Flow %
0.06%
Top 10 Hldgs %
27.05%
Holding
158
New
8
Increased
60
Reduced
23
Closed
11

Top Buys

1
WCG
Wellcare Health Plans, Inc.
WCG
$21.9M
2
UNH icon
UnitedHealth
UNH
$19.6M
3
WST icon
West Pharmaceutical
WST
$15.9M
4
TBIO
Translate Bio, Inc. Common Stock
TBIO
$12.8M
5
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$11.2M

Top Sells

1
BMY icon
Bristol-Myers Squibb
BMY
$41.1M
2
AET
Aetna Inc
AET
$40.4M
3
AVXS
AveXis, Inc. Common Stock
AVXS
$23.5M
4
PRTA icon
Prothena Corp
PRTA
$11.7M
5
PRAH
PRA Health Sciences, Inc.
PRAH
$9.97M

Sector Composition

1 Healthcare 89.32%
2 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BMRN icon
76
BioMarin Pharmaceuticals
BMRN
$10.9B
$11.8M 0.45%
125,000
– –
CLVS
77
DELISTED
Clovis Oncology, Inc.
CLVS
$11.6M 0.45%
255,000
+23,500
+10% +$1.07M
RIGL icon
78
Rigel Pharmaceuticals
RIGL
$720M
$11.2M 0.43%
395,000
+137,500
+53% +$3.89M
TVTX icon
79
Travere Therapeutics
TVTX
$1.89B
$10.9M 0.42%
400,000
– –
ARGX icon
80
argenx
ARGX
$44.9B
$10.7M 0.41%
+128,750
New +$10.7M
ANAB icon
81
AnaptysBio
ANAB
$590M
$10.7M 0.41%
150,000
+15,000
+11% +$1.07M
CLSD icon
82
Clearside Biomedical
CLSD
$27.5M
$10.4M 0.4%
975,000
– –
NVTA
83
DELISTED
Invitae Corporation
NVTA
$10.3M 0.4%
1,400,000
– –
A icon
84
Agilent Technologies
A
$36.4B
$10.1M 0.39%
163,700
+72,200
+79% +$4.46M
ZGNX
85
DELISTED
Zogenix, Inc.
ZGNX
$9.99M 0.38%
226,000
+500
+0.2% +$22.1K
CHRS icon
86
Coherus Oncology, Inc. Common Stock
CHRS
$152M
$9.66M 0.37%
690,000
-5,000
-0.7% -$70K
QTTB icon
87
Q32 Bio
QTTB
$20.2M
$9.59M 0.37%
26,111
-5,833
-18% -$2.14M
FPRX
88
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$9.38M 0.36%
593,000
+7,500
+1% +$119K
ARDX icon
89
Ardelyx
ARDX
$1.58B
$9.35M 0.36%
2,525,557
+250,000
+11% +$925K
ECYT
90
DELISTED
Endocyte, Inc. Common Stock
ECYT
$9.32M 0.36%
675,000
– –
MNTA
91
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$9.25M 0.36%
452,500
+107,500
+31% +$2.2M
SRGA
92
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$8.97M 0.35%
65,000
– –
ADAP
93
Adaptimmune Therapeutics
ADAP
$13.5M
$8.9M 0.34%
750,000
-125,000
-14% -$1.48M
ODT
94
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$8.78M 0.34%
397,750
+14,250
+4% +$315K
CO
95
DELISTED
Global Cord Blood Corporation
CO
$8.35M 0.32%
880,000
– –
APTX
96
DELISTED
Aptinyx Inc. Common Stock
APTX
$8.22M 0.32%
+340,000
New +$8.22M
CBAY
97
DELISTED
Cymabay Therapeutics
CBAY
$7.78M 0.3%
580,000
+90,000
+18% +$1.21M
SPRO icon
98
Spero Therapeutics
SPRO
$120M
$7.7M 0.3%
525,000
– –
SAGE
99
DELISTED
Sage Therapeutics
SAGE
$7.67M 0.3%
49,000
– –
RARX
100
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$7.46M 0.29%
750,000
+150,000
+25% +$1.49M
2 3
4
5 6